Related Experiment Video
Updated: Aug 18, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
The cardiac ryanodine receptor (RyR2) and its role in heart disease
Ying Taur1, William H Frishman
1Department of Medicine, Long Island Jewish Medical Center/Albert Einstein College of Medicine, Manhasset, New York, USA.
Abstract:
The cardiac ryanodine receptor has become a subject of increasing interest as its role in the etiology of cardiac disease is becoming more apparent. In this article, we review the current knowledge of the structure and function of the cardiac ryanodine receptor and its implications in cardiac pathophysiology. Cardiac ryanodine receptors function by regulating calcium release from the sarcoplasmic reticulum in cardiomyocytes, thereby playing an integral role in excitation-contraction coupling. In heart failure, the myocardium remains in a chronic hyperadrenergic state. This leads to protein kinase A hyperphosphorylation of ryanodine receptors within cardiomyocytes, ultimately leading to calcium leakage from the sarcoplasmic reticulum into the cytosol and thus impairing excitation-contraction coupling. These mechanisms could partially explain the pathophysiology underlying the reduced cardiac output seen in heart failure. Beta-adrenergic blockade appears to correct the abnormality and reestablishes normal ryanodine receptor function. These calcium leaks can also generate delayed afterdepolarizations, which can lead to fatal arrhythmias. Two genetic diseases have been linked to mutations in the cardiac ryanodine receptor: arrhythmogenic right ventricular dysplasia type 2 and catecholaminergic polymorphic ventricular tachycardia or familial polymorphic ventricular tachycardia. As our understanding of this receptor and its modulators deepens, the possibility of clinical application draws near.
Insights
The cardiac ryanodine receptor regulates calcium release in heart cells. Dysfunction in heart failure causes calcium leakage, impairing heart function and leading to arrhythmias.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- The cardiac ryanodine receptor (RyR2) is crucial for excitation-contraction coupling in cardiomyocytes.
- Its dysregulation is implicated in various cardiac diseases, including heart failure and arrhythmias.
- Understanding RyR2 structure and function is key to addressing cardiac pathophysiology.
Purpose of the Study:
- To review current knowledge on cardiac ryanodine receptor structure and function.
- To explore the role of RyR2 in cardiac pathophysiology, particularly in heart failure.
- To discuss genetic diseases linked to RyR2 mutations and potential clinical applications.
Main Methods:
- Review of existing literature on cardiac ryanodine receptor.
- Analysis of RyR2's role in calcium regulation and excitation-contraction coupling.
- Examination of RyR2 alterations in heart failure and genetic cardiac conditions.
Main Results:
- In heart failure, chronic hyperadrenergic state leads to RyR2 hyperphosphorylation, causing calcium leakage.
- This calcium leak impairs excitation-contraction coupling and contributes to reduced cardiac output.
- RyR2 dysfunction is linked to delayed afterdepolarizations, potentially causing fatal arrhythmias.
- Mutations in RyR2 are associated with arrhythmogenic right ventricular dysplasia type 2 and catecholaminergic polymorphic ventricular tachycardia.
Conclusions:
- Cardiac ryanodine receptor plays a critical role in normal heart function and its dysfunction contributes to heart failure.
- Therapeutic strategies targeting RyR2, such as beta-adrenergic blockade, can restore normal function.
- Further research into RyR2 and its modulators holds promise for clinical applications in treating cardiac diseases.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Action of Calcium Channel Blockers
